Cargando…
The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey
Purpose: Antimicrobial resistance among microorganisms is a global concern. In 2003, a nationwide antibiotic restriction program (NARP) was released in Turkey. In this study we evaluated the effect of NARP on antibiotic consumption, antimicrobial resistance, and cost. Materials and Methods: The data...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107466/ https://www.ncbi.nlm.nih.gov/pubmed/21647326 |
_version_ | 1782205226049077248 |
---|---|
author | Altunsoy, Adalet Aypak, Cenk Azap, Alpay Ergönül, Önder Balık, İsmail |
author_facet | Altunsoy, Adalet Aypak, Cenk Azap, Alpay Ergönül, Önder Balık, İsmail |
author_sort | Altunsoy, Adalet |
collection | PubMed |
description | Purpose: Antimicrobial resistance among microorganisms is a global concern. In 2003, a nationwide antibiotic restriction program (NARP) was released in Turkey. In this study we evaluated the effect of NARP on antibiotic consumption, antimicrobial resistance, and cost. Materials and Methods: The data obtained from all of the four university hospitals, and one referral tertiary-care educational state hospital in Ankara. Antimicrobial resistance profiles of 14,233 selected microorganisms all grown in blood cultures and antibiotic consumption from 2001 to 2005 were analyzed retrospectively. Results: A negative correlation was observed between the ceftriaxone consumption and the prevalence of ceftriaxone resistant E.coli and Klebsiella spp. (rho:-0.395, p:0.332 and rho:-0.627, p:0.037, respectively). The decreased usage of carbapenems was correlated with decreased carbapenems-resistant Pseudomonas spp. and Acinetobacter spp (rho:0.155, p:0.712 and rho:0.180, p:0.668, respectively for imipenem). Methicillin resistance rates of S.aureus were decreased from 44% to 41%. After two years of NARP 5,389,155.82 USD saving occurred. Conclusion: NARP is effective in lowering the costs and antibiotic resistance. |
format | Online Article Text |
id | pubmed-3107466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-31074662011-06-06 The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey Altunsoy, Adalet Aypak, Cenk Azap, Alpay Ergönül, Önder Balık, İsmail Int J Med Sci Research Paper Purpose: Antimicrobial resistance among microorganisms is a global concern. In 2003, a nationwide antibiotic restriction program (NARP) was released in Turkey. In this study we evaluated the effect of NARP on antibiotic consumption, antimicrobial resistance, and cost. Materials and Methods: The data obtained from all of the four university hospitals, and one referral tertiary-care educational state hospital in Ankara. Antimicrobial resistance profiles of 14,233 selected microorganisms all grown in blood cultures and antibiotic consumption from 2001 to 2005 were analyzed retrospectively. Results: A negative correlation was observed between the ceftriaxone consumption and the prevalence of ceftriaxone resistant E.coli and Klebsiella spp. (rho:-0.395, p:0.332 and rho:-0.627, p:0.037, respectively). The decreased usage of carbapenems was correlated with decreased carbapenems-resistant Pseudomonas spp. and Acinetobacter spp (rho:0.155, p:0.712 and rho:0.180, p:0.668, respectively for imipenem). Methicillin resistance rates of S.aureus were decreased from 44% to 41%. After two years of NARP 5,389,155.82 USD saving occurred. Conclusion: NARP is effective in lowering the costs and antibiotic resistance. Ivyspring International Publisher 2011-05-24 /pmc/articles/PMC3107466/ /pubmed/21647326 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. |
spellingShingle | Research Paper Altunsoy, Adalet Aypak, Cenk Azap, Alpay Ergönül, Önder Balık, İsmail The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey |
title | The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey |
title_full | The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey |
title_fullStr | The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey |
title_full_unstemmed | The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey |
title_short | The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey |
title_sort | impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in turkey |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107466/ https://www.ncbi.nlm.nih.gov/pubmed/21647326 |
work_keys_str_mv | AT altunsoyadalet theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey AT aypakcenk theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey AT azapalpay theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey AT ergonulonder theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey AT balıkismail theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey AT altunsoyadalet impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey AT aypakcenk impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey AT azapalpay impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey AT ergonulonder impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey AT balıkismail impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey |